Targeted GLP-1 nanotherapy for Wnt/β-catenin activation to enhance endothelial progenitor cell-mediated re-endothelialization and prevent intracranial aneurysm recurrence
{{output}}
Objective: Intracranial aneurysm (IA) is a leading cause of subarachnoid hemorrhage, characterized by complex pathogenesis and high mortality rates due to rupture. The aim of this study was to develop a targeted glucagon-like pep... ...
